Test Code DULOX Duloxetine, Serum
Reporting Name
Duloxetine, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Monitoring duloxetine serum concentration during therapy
Evaluating potential duloxetine toxicity
Evaluating patient compliance
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Specimen Required
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Draw blood immediately before the next scheduled dose (trough).
2. Centrifuge and aliquot serum into plastic vial within 2 hours of collection.
Specimen Type
Serum RedSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum Red | Refrigerated (preferred) | 28 days | |
Ambient | 28 days | ||
Frozen | 28 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
30-120 ng/mLInterpretation
Therapeutic ranges are not well-established, but literature suggests that patients receiving duloxetine monotherapy for depression responded well when trough concentrations were 30 to 120 ng/mL. Higher levels may be tolerated by individual patients. The therapeutic relevance of this concentration range to other uses of duloxetine therapy is currently unknown.
Day(s) Performed
Wednesday
Report Available
1 to 8 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80299
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
DULOX | Duloxetine, S | 46227-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
89305 | Duloxetine, S | 46227-5 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.